GeneDx Holdings Corp (NASDAQ:WGS) price on Thursday, July 03, rose 2.03% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $91.61.
A look at the stock’s price movement, the close in the last trading session was $89.79, moving within a range at $88.785 and $92.785. The beta value (5-Year monthly) was 2.01. Turning to its 52-week performance, $117.75 and $25.32 were the 52-week high and 52-week low respectively. Overall, WGS moved 25.82% over the past month.
GeneDx Holdings Corp’s market cap currently stands at around $2.61 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-30.
Turning to the stock’s technical picture we see that short term indicators suggest on average that WGS is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend WGS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
WGS’s current price about 18.13% and 21.60% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 66.50, while 7-day volatility ratio is 4.06% and 6.69% in the 30-day chart. Further, GeneDx Holdings Corp (WGS) has a beta value of 2.08. Analysts have given the company’s stock an average 52-week price target of $39.5, forecast between a low of $21 and high of $70. Looking at the price targets, the low is 77.08% off current price level while to achieve the yearly target high, price needs to move 23.59%. Nonetheless, investors will most likely welcome a 56.88% jump to $39.5 which is the analysts’ median price.
If we refocus on GeneDx Holdings Corp (NASDAQ:WGS), historical trading data shows that trading volumes averaged 1.19 over the past 10 days and 1.19 million over the past 3 months. The company’s latest data on shares outstanding shows there are 28.53 million shares.
The 12.85% of GeneDx Holdings Corp’s shares are in the hands of company insiders while institutional holders own 101.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.75 million on 2025-06-13, giving us a short ratio of 4.35. The data shows that as of 2025-06-13 short interest in GeneDx Holdings Corp (WGS) stood at 2651.0 of shares outstanding, with shares short rising to 3.47 million registered in 2025-05-15. Current price change has pushed the stock 219.31% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the WGS stock continues to rise going into the next quarter.
